{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T04:04:05Z","timestamp":1742875445172,"version":"3.40.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Lianqin Medical Key Specialty Projectthe Project","award":["LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW"],"award-info":[{"award-number":["LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW","LQZD-SW"]}]},{"name":"the Fujian Provincial Science and Technology Innovation Platform Project","award":["2022Y2017","2022Y2017","2022Y2017","2022Y2017","2022Y2017","2022Y2017","2022Y2017"],"award-info":[{"award-number":["2022Y2017","2022Y2017","2022Y2017","2022Y2017","2022Y2017","2022Y2017","2022Y2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The growth hormone (GH) level on postoperative day one (POD1), i.e., POD1GH, holds significant value in assessing surgical efficacy and predicting long-term remission in patients with acromegaly. This study aims to explore the factors that influence the GH level of POD1 after microscopic transsphenoidal surgery (mTSS) in patients with acromegaly, providing insights for preoperative clinical decisions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 85 acromegaly patients undergoing mTSS were included in this study. Sex; age; body mass index (BMI); preoperative serum hormone levels and tumor characteristics were assessed for their correlation with POD1GH levels. POD1GH level non-remission, defined as POD1GH\u2009&gt;\u20092.5\u2009ng\/mL, was considered an outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The patients with acromegaly were divided into two groups: adult males (43 cases) and adult females (42 cases), with mean ages of 43.33\u2009\u00b1\u200911.92 years and 47.02\u2009\u00b1\u200914.18 years, respectively. Correlation and multivariate linear regression analyses revealed positive correlations of preoperative GH and prolactin (PRL) levels in females with POD1GH levels, while preoperative FT3 and TT levels in males were negatively correlated with POD1GH levels. Binary logistic regression and receiver operating characteristic (ROC) analyses identified preoperative GH levels \u226530.25\u2009ng\/mL (OR\u2009=\u20092.236, 95%CI\u2009=\u20091.402\u20133.567, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), FT3 levels \u22644.415\u2009pmol\/L (OR\u2009=\u20090.329, 95%CI\u2009=\u20090.167\u20130.648, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and age \u226451 years (OR\u2009=\u20090.566, 95%CI\u2009=\u20090.352\u20130.911, <jats:italic>p<\/jats:italic>\u2009=\u20090.019) as independent risk factors for POD1GH level non-remission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Preoperative GH, FT3, TT, and PRL levels are correlated with POD1GH levels, with variations observed between sex. Age, preoperative GH, and FT3 levels can predict POD1GH level non-remission. Therefore, the comprehensive consideration of multiple hormone axes is necessary for predicting postoperative efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12020-024-04130-6","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T16:10:24Z","timestamp":1734711024000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of growth hormone level on postoperative day one in patients with acromegaly"],"prefix":"10.1007","volume":"88","author":[{"given":"Haixiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangfeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-7846","authenticated-orcid":false,"given":"Shousen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"11","key":"4130_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"M. Fleseriu, F. Langlois, D.S.T. Lim et al. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11), 804\u2013826 (2022). https:\/\/doi.org\/10.1016\/S2213-8587(22)00244-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4130_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.807054","volume":"12","author":"X Guo","year":"2022","unstructured":"X. Guo, R. Zhang, D. Zhang et al. Hyperprolactinemia and hypopituitarism in acromegaly and effect of pituitary surgery: long-term follow-up on 529 patients. Front Endocrinol 12, 807054 (2022). https:\/\/doi.org\/10.3389\/fendo.2021.807054","journal-title":"Front Endocrinol"},{"issue":"4","key":"4130_CR3","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2010.7.FOCUS10173","volume":"29","author":"CP Hofstetter","year":"2010","unstructured":"C.P. Hofstetter, R.H. Mannaa, L. Mubita et al. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus 29(4), E6 (2010). https:\/\/doi.org\/10.3171\/2010.7.FOCUS10173","journal-title":"Neurosurg Focus"},{"issue":"2","key":"4130_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-020-03669-4","volume":"151","author":"S Yao","year":"2021","unstructured":"S. Yao, W.L. Chen, S. Tavakol et al. Predictors of postoperative biochemical remission in acromegaly. J Neurooncol 151(2), 313\u2013324 (2021). https:\/\/doi.org\/10.1007\/s11060-020-03669-4","journal-title":"J Neurooncol"},{"key":"4130_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.924589","volume":"13","author":"DP Bray","year":"2022","unstructured":"D.P. Bray, S. Mannam, R.S. Rindler et al. Surgery for acromegaly: Indications and goals. Front Endocrinol 13, 924589 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.924589","journal-title":"Front Endocrinol"},{"issue":"11","key":"4130_CR6","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s40618-021-01553-0","volume":"44","author":"V Cambria","year":"2021","unstructured":"V. Cambria, G. Beccuti, N. Prencipe et al. First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence. J Endocrinol Investig 44(11), 2427\u20132433 (2021). https:\/\/doi.org\/10.1007\/s40618-021-01553-0","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"4130_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12020-018-1590-8","volume":"60","author":"X Antunes","year":"2018","unstructured":"X. Antunes, N. Ventura, G.B. Camilo et al. Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3), 415\u2013422 (2018). https:\/\/doi.org\/10.1007\/s12020-018-1590-8","journal-title":"Endocrine"},{"issue":"3","key":"4130_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1365-2265.1996.8080817.x","volume":"45","author":"S Yamada","year":"1996","unstructured":"S. Yamada, T. Aiba, K. Takada et al. Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome. Clin Endocrinol 45(3), 291\u2013298 (1996). https:\/\/doi.org\/10.1046\/j.1365-2265.1996.8080817.x","journal-title":"Clin Endocrinol"},{"issue":"6","key":"4130_CR9","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2020.3.FOCUS2061","volume":"48","author":"R Rotermund","year":"2020","unstructured":"R. Rotermund, M.M. Mader, T. Burkhardt et al. Real-life analysis of 280 patients with surgically treated acromegaly: a single-center experience from 2008 to 2015. Neurosurg Focus 48(6), E9 (2020). https:\/\/doi.org\/10.3171\/2020.3.FOCUS2061","journal-title":"Neurosurg Focus"},{"issue":"5","key":"4130_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11102-020-01063-x","volume":"23","author":"N Agrawal","year":"2020","unstructured":"N. Agrawal, A.G. Ioachimescu, Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review. Pituitary 23(5), 582\u2013594 (2020). https:\/\/doi.org\/10.1007\/s11102-020-01063-x","journal-title":"Pituitary"},{"key":"4130_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2021.11.JNS212137","volume":"14","author":"X Guo","year":"2022","unstructured":"X. Guo, R. Zhang, D. Zhang et al. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients. J Neurosurg 14, 1\u201311 (2022). https:\/\/doi.org\/10.3171\/2021.11.JNS212137","journal-title":"J Neurosurg"},{"issue":"22","key":"4130_CR12","doi-asserted-by":"publisher","first-page":"16162","DOI":"10.3390\/ijms242216162","volume":"24","author":"RI Dumitriu-Stan","year":"2023","unstructured":"R.I. Dumitriu-Stan, I.F. Burcea, V.N. Nastase et al. The value of ER\u221d in the prognosis of GH- and PRL-secreting PitNETs: clinicopathological correlations. Int J Mol Sci 24(22), 16162 (2023). https:\/\/doi.org\/10.3390\/ijms242216162","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4130_CR13","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2022.9.FOCUS226","volume":"53","author":"Z Pei","year":"2022","unstructured":"Z. Pei, Y. Fang, S. Mu et al. Perioperative fluctuation and overall evaluation of adenohypophyseal hormone secretion in patients with nonfunctioning pituitary adenoma. Neurosurg Focus 53(6), E10 (2022). https:\/\/doi.org\/10.3171\/2022.9.FOCUS226","journal-title":"Neurosurg Focus"},{"issue":"1","key":"4130_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/cancers15010267","volume":"15","author":"A Ferr\u00e9s","year":"2022","unstructured":"A. Ferr\u00e9s, L. Reyes, A. Di Somma et al. The prognostic-based approach in growth hormone-secreting Pituitary Neuroendocrine Tumors (PitNET): tertiary reference center, single senior surgeon, and long-term follow-up. Cancers 15(1), 267 (2022). https:\/\/doi.org\/10.3390\/cancers15010267","journal-title":"Cancers"},{"key":"4130_CR15","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1016\/j.wneu.2021.01.019","volume":"149","author":"T Rahimli","year":"2021","unstructured":"T. Rahimli, T. Hidayetov, Z. Yusifli et al. Endoscopic endonasal approach to giant pituitary adenomas: surgical outcomes and review of the literature. World Neurosurg 149, e1043\u2013e1055 (2021). https:\/\/doi.org\/10.1016\/j.wneu.2021.01.019","journal-title":"World Neurosurg"},{"issue":"12","key":"4130_CR16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1089\/thy.2008.0266","volume":"18","author":"M Losa","year":"2008","unstructured":"M. Losa, M. Scavini, E. Gatti et al. Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency. Thyroid 18(12), 1249\u20131254 (2008). https:\/\/doi.org\/10.1089\/thy.2008.0266","journal-title":"Thyroid"},{"issue":"2","key":"4130_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12020-017-1495-y","volume":"59","author":"I Yamauchi","year":"2018","unstructured":"I. Yamauchi, Y. Sakane, T. Yamashita et al. Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans. Endocrine 59(2), 353\u2013363 (2018). https:\/\/doi.org\/10.1007\/s12020-017-1495-y","journal-title":"Endocrine"},{"issue":"12","key":"4130_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1055\/s-2007-1010940","volume":"20","author":"PC Eskildsen","year":"1988","unstructured":"P.C. Eskildsen, A. Kruse, C. Kirkegaard, The pituitary-thyroid axis in acromegaly. Horm Metab Res 20(12), 755\u2013757 (1988). https:\/\/doi.org\/10.1055\/s-2007-1010940","journal-title":"Horm Metab Res"},{"issue":"10","key":"4130_CR19","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1210\/jc.2019-00466","volume":"104","author":"T Takamizawa","year":"2019","unstructured":"T. Takamizawa, K. Horiguchi, Y. Nakajima et al. Central hypothyroidism related to pituitary adenomas: low incidence of central hypothyroidism in patients with acromegaly. J Clin Endocrinol Metab 104(10), 4879\u20134888 (2019). https:\/\/doi.org\/10.1210\/jc.2019-00466","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4130_CR20","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3171\/2019.8.JNS191012","volume":"133","author":"AS Little","year":"2019","unstructured":"A.S. Little, P.A. Gardner, J.C. Fernandez-Miranda,TRANSSPHER Study Group et al., Pituitary gland recovery following fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenoma: results of a prospective multicenter study. J Neurosurg. 133(6), 1732\u20131738 (2019). https:\/\/doi.org\/10.3171\/2019.8.JNS191012","journal-title":"J Neurosurg."},{"issue":"8","key":"4130_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1507\/endocrj.EJ20-0596","volume":"68","author":"R Nishio","year":"2021","unstructured":"R. Nishio, A. Takeshita, T. Uchida et al. GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly. Endocr J 68(8), 953\u2013968 (2021). https:\/\/doi.org\/10.1507\/endocrj.EJ20-0596","journal-title":"Endocr J"},{"issue":"1","key":"4130_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40618-023-02131-2","volume":"47","author":"F Pallotti","year":"2024","unstructured":"F. Pallotti, D. Costa, M.N. Hirsch et al. Erectile function and androgen and estrogen beta receptor gene polymorphisms in acromegalic men. J Endocrinol Investig 47(1), 141\u2013147 (2024). https:\/\/doi.org\/10.1007\/s40618-023-02131-2","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"4130_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11154-022-09721-0","volume":"23","author":"G Salvio","year":"2022","unstructured":"G. Salvio, M. Martino, G. Balercia et al. Acromegaly and male sexual health. Rev Endocr Metab Disord 23(3), 671\u2013678 (2022). https:\/\/doi.org\/10.1007\/s11154-022-09721-0","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"4130_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/a-1207-1132","volume":"52","author":"D Van Laethem","year":"2020","unstructured":"D. Van Laethem, A. Michotte, W. Cools et al. Hyperprolactinemia in acromegaly is related to prolactin secretion by somatolactotroph tumours. Horm Metab Res 52(9), 647\u2013653 (2020). https:\/\/doi.org\/10.1055\/a-1207-1132","journal-title":"Horm Metab Res"},{"key":"4130_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1259529","volume":"14","author":"D Zhang","year":"2023","unstructured":"D. Zhang, X. Guo, M. Feng et al. Preoperative and postoperative blood testosterone levels in patients with acromegaly: a prospective study. Front Endocrinol 14, 1259529 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1259529","journal-title":"Front Endocrinol"},{"key":"4130_CR26","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.2147\/DMSO.S429941","volume":"16","author":"J Du","year":"2023","unstructured":"J. Du, X. Zhao, X. Xu et al. Association between thyroid parameters and subclinical atherosclerosis in hospitalised euthyroid patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 16, 3163\u20133171 (2023). https:\/\/doi.org\/10.2147\/DMSO.S429941","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"4130_CR27","doi-asserted-by":"publisher","first-page":"e220424","DOI":"10.1530\/EC-22-0424","volume":"12","author":"Q Jin","year":"2023","unstructured":"Q. Jin, G. Huang, X. Tian et al. High free triiodothyronine, and free-triiodothyronine-to-free-thyroxine ratio are associated with metabolic syndrome in a euthyroid employee population: the Zhejiang Zhenhai study. Endocr Connect 12(5), e220424 (2023). https:\/\/doi.org\/10.1530\/EC-22-0424","journal-title":"Endocr Connect"},{"issue":"2","key":"4130_CR28","first-page":"149","volume":"35","author":"GH Wu","year":"2014","unstructured":"G.H. Wu, F.Z. Kong, Q.Z. Cheng et al. Low T3 syndrome predicts severe neurological deficits of cerebral infarction inpatients with large artery artherosclerosis in internal carotid artery system. Neuro Endocrinol Lett 35(2), 149\u2013153 (2014)","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"4130_CR29","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1210\/jc.2009-0174","volume":"94","author":"F Roelfsema","year":"2009","unstructured":"F. Roelfsema, N.R. Biermasz, M. Frolich et al. Diminished and irregular thyrotropin secretion with preserved diurnal rhythm in patients with active acromegaly. J Clin Endocrinol Metab 94(6), 1945\u20131950 (2009). https:\/\/doi.org\/10.1210\/jc.2009-0174","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4130_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/1751-2980.12609","volume":"19","author":"WQ Yang","year":"2018","unstructured":"W.Q. Yang, Q. Yang, W.J. Chen et al. Low FT3 is a valuable predictor of severe acute pancreatitis in the emergency department. J Dig Dis 19(7), 431\u2013438 (2018). https:\/\/doi.org\/10.1111\/1751-2980.12609","journal-title":"J Dig Dis"},{"issue":"17","key":"4130_CR31","doi-asserted-by":"publisher","first-page":"29282","DOI":"10.18632\/oncotarget.16502","volume":"8","author":"LB Mitrofanova","year":"2017","unstructured":"L.B. Mitrofanova, P.V. Konovalov, J.S. Krylova et al. Plurihormonal cells of normal anterior pituitary: Facts and conclusions. Oncotarget 8(17), 29282\u201329299 (2017). https:\/\/doi.org\/10.18632\/oncotarget.16502","journal-title":"Oncotarget"},{"issue":"1","key":"4130_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/andr.12918","volume":"9","author":"M Tenuta","year":"2021","unstructured":"M. Tenuta, F. Carlomagno, B. Cangiano et al. Somatotropic-testicular axis: a crosstalk between GH\/IGF-I and gonadal hormones during development, transition, and adult age. Andrology 9(1), 168\u2013184 (2021). https:\/\/doi.org\/10.1111\/andr.12918","journal-title":"Andrology"},{"issue":"1","key":"4130_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1095\/biolreprod.103.027060","volume":"71","author":"V Chandrashekar","year":"2004","unstructured":"V. Chandrashekar, D. Zaczek, A. Bartke, The consequences of altered somatotropic system on reproduction. Biol Reprod 71(1), 17\u201327 (2004). https:\/\/doi.org\/10.1095\/biolreprod.103.027060","journal-title":"Biol Reprod"},{"key":"4130_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fendo.2018.00131","volume":"9","author":"J Chen","year":"2018","unstructured":"J. Chen, M. Cao, A. Zhang et al. Growth hormone overexpression disrupts reproductive status through actions on leptin. Front Endocrinol 9, 131 (2018). https:\/\/doi.org\/10.3389\/fendo.2018.00131","journal-title":"Front Endocrinol"},{"issue":"9","key":"4130_CR35","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1210\/jc.2002-020453","volume":"87","author":"A Colao","year":"2002","unstructured":"A. Colao, M. De Rosa, R. Pivonello et al. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. J Clin Endocrinol Metab 87(9), 4193\u20134197 (2002). https:\/\/doi.org\/10.1210\/jc.2002-020453","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4130_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14341\/probl12791","volume":"68","author":"EE Sakhnova","year":"2021","unstructured":"E.E. Sakhnova, E.G. Przhiyalkovskaya, Z.E. Belaya et al. Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly. Probl Endokrinol 68(1), 40\u201348 (2021). https:\/\/doi.org\/10.14341\/probl12791","journal-title":"Probl Endokrinol"},{"issue":"3","key":"4130_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2002-23197","volume":"34","author":"L De Marinis","year":"2002","unstructured":"L. De Marinis, P. Zuppi, D. Valle et al. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. Horm Metab Res 34(3), 137\u2013143 (2002). https:\/\/doi.org\/10.1055\/s-2002-23197","journal-title":"Horm Metab Res"},{"key":"4130_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.957301","volume":"13","author":"A Tomasik","year":"2022","unstructured":"A. Tomasik, M. Stelmachowska-Bana\u015b, M. Maksymowicz et al. Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly. Front Endocrinol 13, 957301 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.957301","journal-title":"Front Endocrinol"},{"issue":"6","key":"4130_CR39","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2020.3.FOCUS2080","volume":"48","author":"T Cardinal","year":"2020","unstructured":"T. Cardinal, M.J. Rutkowski, A. Micko et al. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Neurosurg Focus 48(6), E10 (2020). https:\/\/doi.org\/10.3171\/2020.3.FOCUS2080","journal-title":"Neurosurg Focus"},{"issue":"12","key":"4130_CR40","doi-asserted-by":"publisher","first-page":"dgaa664","DOI":"10.1210\/clinem\/dgaa664","volume":"105","author":"M Mercado","year":"2020","unstructured":"M. Mercado, C. Abreu, A. Vergara-L\u00f3pez et al. Surgical and pharmacological outcomes in acromegaly: real-life data from the Mexican Acromegaly Registry. J Clin Endocrinol Metab 105(12), dgaa664 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa664","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4130_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00701-014-2098-5","volume":"156","author":"S Sarkar","year":"2014","unstructured":"S. Sarkar, K.S. Jacob, R. Pratheesh, A.G. Chacko, Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays. Acta Neurochir 156(7), 1379\u20131387 (2014). https:\/\/doi.org\/10.1007\/s00701-014-2098-5","journal-title":"Acta Neurochir"},{"key":"4130_CR42","doi-asserted-by":"publisher","first-page":"e882","DOI":"10.1016\/j.wneu.2023.12.076","volume":"182","author":"S Cohen-Cohen","year":"2023","unstructured":"S. Cohen-Cohen, R. Rindler, E. Botello Hernandez et al. A novel preoperative score to predict long-term biochemical remission in patients with growth-hormone secreting pituitary adenomas. World Neurosurg 182, e882\u2013e890 (2023). https:\/\/doi.org\/10.1016\/j.wneu.2023.12.076","journal-title":"World Neurosurg"},{"key":"4130_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.wneu.2015.12.092","volume":"88","author":"O Haliloglu","year":"2016","unstructured":"O. Haliloglu, E. Kuruoglu, H.M. Ozkaya et al. Multidisciplinary approach for acromegaly: a single tertiary center\u2019s experience. World Neurosurg 88, 270\u2013276 (2016). https:\/\/doi.org\/10.1016\/j.wneu.2015.12.092","journal-title":"World Neurosurg"},{"issue":"3","key":"4130_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/1591019915582367","volume":"21","author":"D Iancu","year":"2015","unstructured":"D. Iancu, C. Lum, M.E. Ahmed et al. Flow diversion in the treatment of carotid injury and carotid-cavernous fistula after transsphenoidal surgery. Interv Neuroradiol 21(3), 346\u2013350 (2015). https:\/\/doi.org\/10.1177\/1591019915582367","journal-title":"Interv Neuroradiol"},{"issue":"5","key":"4130_CR45","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11102-016-0728-z","volume":"19","author":"Y Sasagawa","year":"2016","unstructured":"Y. Sasagawa, O. Tachibana, M. Doai et al. Carotid artery protrusion and dehiscence in patients with acromegaly. Pituitary 19(5), 482\u2013487 (2016). https:\/\/doi.org\/10.1007\/s11102-016-0728-z","journal-title":"Pituitary"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04130-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04130-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04130-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:45:56Z","timestamp":1742802356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04130-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["4130"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04130-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}